Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

BACKGROUND: The activities of MYC, the androgen receptor, and its associated pioneer factors demonstrate substantial reprogramming between early and advanced prostate cancer. Although previous studies have shown a shift in cellular metabolic requirements associated with prostate cancer progression,...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitlock, Nichelle C., White, Margaret E., Capaldo, Brian J., Ku, Anson T., Agarwal, Supreet, Fang, Lei, Wilkinson, Scott, Trostel, Shana Y., Shi, Zhen-Dan, Basuli, Falguni, Wong, Karen, Jagoda, Elaine M., Kelly, Kathleen, Choyke, Peter L., Sowalsky, Adam G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526773/
https://www.ncbi.nlm.nih.gov/pubmed/36181613
http://dx.doi.org/10.1007/s12672-022-00565-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526773/
https://www.ncbi.nlm.nih.gov/pubmed/36181613
http://dx.doi.org/10.1007/s12672-022-00565-3

Ejemplares similares